title: Evaluation of the 7th AJCC TNM Staging System in Point of Lymph Node Classification.
abstract: OBJECTIVE
  The 7th AJCC tumor node metastasis (TNM) staging system modified the classification of the lymph node metastasis widely compared to the 6th edition. To evaluate the prognostic predictability of the new TNM staging system, we analyzed the survival rate of the gastric cancer patients assessed by the 7th staging system.
  
  
  METHODS
  Among 2,083 patients who underwent resection for gastric cancer at the department of surgery, Hanyang Medical Center from July 1992 to December 2009, This study retrospectively reviewed 5-year survival rate (5YSR) of 624 patients (TanyN3M0: 464 patients, TanyNanyM1: 160 patients) focusing on the number of metastatic lymph node and distant metastasis. We evaluated the applicability of the new staging system.
  
  
  RESULTS
  There were no significant differences in 5YSR between stage IIIC with more than 29 metastatic lymph nodes and stage IV (P=0.053). No significant differences were observed between stage IIIB with more than 28 metastatic lymph nodes and stage IV (P=0.093). Distinct survival differences were present between patients who were categorized as TanyN3M0 with 7 to 32 metastatic lymph nodes and stage IV. But patients with more than 33 metastatic lymph nodes did not show any significant differences compared to stage IV (P=0.055). Among patients with TanyN3M0, statistical significances were seen between patients with 7 to 30 metastatic lymph nodes and those with more than 31 metastatic lymph nodes.
  
  
  CONCLUSIONS
  In the new staging system, modifications of N classification is mandatory to improve prognostic prediction. Further study involving a greater number of cases is required to demonstrate the most appropriate cutoffs for N classification.
authors.affiliation: Department of Surgery, Hanyang University College of Medicine, Seoul, Korea.
authors.forename: Sung Hoo
authors.initials: SH
authors.lastname: Kim
authors.forename: Tae Kyung
authors.initials: TK
authors.lastname: Ha
authors.forename: Sung Joon
authors.initials: SJ
authors.lastname: Kwon
references.citation: Ann Surg. 2000 Sep;232(3):362-71
references.pmid: 10973386
references.citation: Cancer. 2000 Apr 15;88(8):1796-800
references.pmid: 10760754
references.citation: Br J Cancer. 2001 Jan 5;84(1):64-71
references.pmid: 11139315
references.citation: Cancer. 1999 Aug 15;86(4):553-8
references.pmid: 10440681
references.citation: J Exp Clin Cancer Res. 2004 Jun;23(2):215-24
references.pmid: 15354405
references.citation: World J Surg. 1999 Jul;23(7):664-9
references.pmid: 10390583
references.citation: Hepatogastroenterology. 2002 May-Jun;49(45):860-4
references.pmid: 12064008
references.citation: Eur J Surg Oncol. 1999 Jun;25(3):280-3
references.pmid: 10336808
references.citation: Br J Surg. 1999 May;86(5):685-9
references.pmid: 10361195
references.citation: CA Cancer J Clin. 2008 May-Jun;58(3):180-90
references.pmid: 18460593
references.citation: World J Surg. 1999 May;23(5):492-7; discussion 497-8
references.pmid: 10085399
references.citation: Cancer. 2000 Apr 15;88(8):1763-5
references.pmid: 10760749
references.citation: Hepatogastroenterology. 1999 Nov-Dec;46(30):3281-6
references.pmid: 10626202
references.citation: Surgery. 2000 Feb;127(2):129-35
references.pmid: 10686976
references.citation: Cancer. 1998 Feb 15;82(4):621-31
references.pmid: 9477092
references.citation: Gastric Cancer. 2004;7(3):140-8
references.pmid: 15449201
references.citation: Tumori. 2004 Sep-Oct;90(5):467-72
references.pmid: 15656331